Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,000
Closed -$22K 7115
2019
Q2
$22K Hold
1,000
﹤0.01% 6398
2019
Q1
$24K Buy
+1,000
New +$23.4K ﹤0.01% 6284

Other funds holding TBI

Barclays's TBI Position: Q1 2026 in Review

Barclays reduced its Trueblue (TBI) stake by 47% in Q1 2026, selling an estimated $175K and leaving 44,369 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3773.

Barclays first reported a position in TBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.33M in Q1 2018. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Barclays held 44,369 shares of Trueblue worth $173K as of Q1 2026.
  • Barclays sold 39,513 Trueblue shares in Q1 2026, an estimated $175K.
  • Trueblue made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3773 holding.
  • Barclays first reported a position in Trueblue in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Trueblue position peaked at $2.33M in Q1 2018.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.